OncXerna Therapeutics, Inc.
PrivateLast Round
Series B
Jan 28, 2021
Total Funding Raised
$126.5M
Company Overview
OncXerna Therapeutics, Inc. is a biotechnology company that develops targeted oncology therapies by leveraging an RNA-expression based biomarker platform to match patients with specific treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncXerna Therapeutics, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
OncXerna Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 28, 2021 | ||||
| Series B | Jun 10, 2019 | ||||
| Seed | Jun 7, 2018 |
OncXerna Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Merchants Bank | Seed |
| Korea Investment Partners | Series B |
| Bencao Capital | Series B |
| Nan Fung Life Sciences | Series B, Seed |
| Volcanics Venture | Seed |
| Panacea Venture Healthcare | Series B |
| Pivotal bioVenture Partners China | Series B, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2021
$30M round with participation from Nan Fung Life Sciences and Bencao Capital.
- Jun 7, 2018
$17M round led by Pivotal bioVenture Partners China.
OncXerna Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OncXerna Therapeutics, Inc.'s valuation, stock price, and market status.